Minerva Neurosciences | NERV - 市值

股票价格
5.51
每天变化
0 0%
每月一次
-29.72%
每年
251.47%
Q2 预测
5.36




市值 更改 日
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Adma Biologics USD 4.34B 845M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Alterity Therapeutics Limited AUD 30M 26M 2026-04
AstraZeneca USD 288.15B 55.08B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 144.67M 7.17M 2025-12
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 292.21B 26.55B 2025-12
Novavax USD 1.09B 316M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12